Articles

Merck’s stock was headed lower in early trading Tuesday, after the drugmaker reported second-quarter profit and sales that beat expectations, amid strength in sales of cancer treatment Keytruda, but provided a mixed full-year outlook.

ADM said it faced “challenging market conditions” and that large South American crops and shifts in farmer selling behaviors impacted its second-quarter results, but it expects margin opportunities to improve.

Pfizer offered an update on a cost-cutting program and raised full-year guidance on Tuesday.

Oil futures hovered near unchanged early Tuesday, unable to shake off recent weakness tied to concerns about the outlook for demand from China, the world’s largest crude importer.

SoFi’s third-quarter revenue outlook exceeded the consensus view.

PayPal on Tuesday posted upbeat growth in transaction-margin dollars for its June quarter, surprising investors on a key metric that gauges the company’s ability to grow profitably.

Striking down EPA’s ‘clean car’ standards would be costly to Americans’ savings and health.

Meaningful balances require continuous coverage, and for that we need a national mandate

The U.S. economy and the stock market can thrive even if inflation doesn’t fall to 2%.

The market’s reaction to the July unemployment rate will speak volumes

New clinical-trial data provide powerful evidence that GLP-1 drugs widely taken for weight loss may also help protect against dementia.

MNC Capital is trying to buy all of Vista for $42 a share, or a total of $3.2 billion, while the Czechoslovak Group was seeking to buy The Kinetic Group for $2.1 billion.